4/1
02:31 pm
mdt
Medtronic (MDT) had its price target raised by Barclays PLC from $118.00 to $120.00. They now have an "overweight" rating on the stock.
Low
Report
Medtronic (MDT) had its price target raised by Barclays PLC from $118.00 to $120.00. They now have an "overweight" rating on the stock.
4/1
02:11 pm
mdt
Medtronic (MDT) had its price target lowered by Piper Sandler from $105.00 to $91.00. They now have a "neutral" rating on the stock.
Low
Report
Medtronic (MDT) had its price target lowered by Piper Sandler from $105.00 to $91.00. They now have a "neutral" rating on the stock.
3/28
05:27 pm
mdt
Jim Cramer on Medtronic (MDT): “I Think That Everything They've Been Doing Lately Is Right” [Yahoo! Finance]
Low
Report
Jim Cramer on Medtronic (MDT): “I Think That Everything They've Been Doing Lately Is Right” [Yahoo! Finance]
3/27
09:00 am
mdt
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
Low
Report
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
3/27
08:28 am
mdt
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
Low
Report
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
3/26
08:02 am
mdt
Medtronic (MDT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $120.00 price target on the stock.
Low
Report
Medtronic (MDT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $120.00 price target on the stock.
3/24
09:09 am
mdt
Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain [TheStreet.com]
Low
Report
Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain [TheStreet.com]
3/23
09:00 am
mdt
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
Low
Report
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
3/19
08:10 pm
mdt
Bone Void Fillers Market Size to Surpass USD 7.31 Billion by 2035; Rising Orthopedic Procedures Driving Market Growth Globally – SNS Insider [Yahoo! Finance]
Low
Report
Bone Void Fillers Market Size to Surpass USD 7.31 Billion by 2035; Rising Orthopedic Procedures Driving Market Growth Globally – SNS Insider [Yahoo! Finance]
3/18
08:53 am
mdt
Vessel Sealing Devices Market Size to Reach USD 4.49 Billion by 2035; Rising Adoption of Minimally Invasive Surgeries and Advanced Energy-Based Surgical Technologies Driving Market Growth – SNS Insider [Yahoo! Finance]
Low
Report
Vessel Sealing Devices Market Size to Reach USD 4.49 Billion by 2035; Rising Adoption of Minimally Invasive Surgeries and Advanced Energy-Based Surgical Technologies Driving Market Growth – SNS Insider [Yahoo! Finance]
3/18
01:11 am
mdt
Medtronic (MDT) Strengthens Neurovascular Platform with Scientia Vascular Purchase [Yahoo! Finance]
Low
Report
Medtronic (MDT) Strengthens Neurovascular Platform with Scientia Vascular Purchase [Yahoo! Finance]
3/18
12:11 am
mdt
[Latest] Global Surgical Stapling Devices Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]
Low
Report
[Latest] Global Surgical Stapling Devices Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]
3/13
09:02 am
mdt
Heart-Lung Machine Market Projected to Hit USD 4.66 Billion by 2035, Owing to Rising Cardiac Surgeries Globally – SNS Insider [Yahoo! Finance]
Low
Report
Heart-Lung Machine Market Projected to Hit USD 4.66 Billion by 2035, Owing to Rising Cardiac Surgeries Globally – SNS Insider [Yahoo! Finance]
3/12
05:19 am
mdt
Medtronic (MDT) Announces Quarterly Dividend of $0.71 per Share [Yahoo! Finance]
Low
Report
Medtronic (MDT) Announces Quarterly Dividend of $0.71 per Share [Yahoo! Finance]
3/10
12:06 pm
mdt
Medtronic (MDT) had its "outperform" rating reaffirmed by Leerink Partners.
Low
Report
Medtronic (MDT) had its "outperform" rating reaffirmed by Leerink Partners.
3/10
12:06 pm
mdt
Medtronic (MDT) had its "buy" rating reaffirmed by Needham & Company LLC.
Low
Report
Medtronic (MDT) had its "buy" rating reaffirmed by Needham & Company LLC.
3/10
06:45 am
mdt
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Low
Report
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
3/9
05:20 pm
mdt
MiniMed announces closing of Initial Public Offering [Yahoo! Finance]
Low
Report
MiniMed announces closing of Initial Public Offering [Yahoo! Finance]
3/6
09:26 am
mdt
MiniMed to begin trading on Nasdaq Global Select Market [Yahoo! Finance]
Low
Report
MiniMed to begin trading on Nasdaq Global Select Market [Yahoo! Finance]
3/6
09:00 am
mdt
MiniMed to begin trading on Nasdaq Global Select Market
Low
Report
MiniMed to begin trading on Nasdaq Global Select Market
3/5
07:35 pm
mdt
MiniMed announces pricing of initial public offering
Low
Report
MiniMed announces pricing of initial public offering
3/5
07:33 pm
mdt
MiniMed announces pricing of initial public offering
Low
Report
MiniMed announces pricing of initial public offering
3/5
05:36 pm
mdt
Medtronic plc declares $0.71 dividend [Seeking Alpha]
Low
Report
Medtronic plc declares $0.71 dividend [Seeking Alpha]
3/5
05:13 pm
mdt
Medtronic announces cash dividend for fourth quarter of fiscal year 2026 [Yahoo! Finance]
Low
Report
Medtronic announces cash dividend for fourth quarter of fiscal year 2026 [Yahoo! Finance]
3/5
04:53 pm
mdt
Medtronic announces cash dividend for fourth quarter of fiscal year 2026
Low
Report
Medtronic announces cash dividend for fourth quarter of fiscal year 2026